Please login to the form below

Not currently logged in
Email:
Password:

Actavis looks to PepsiCo for CFO

Maria Teresa Hilado will help guide company through Allergan aquisition
Maria Teresa Hilado actavis

Maria Teresa Hilado has left her role at PepsiCo to join pharma company Actavis as chief financial officer.

Hilado was most recently senior VP, finance and treasurer at PepsiCo, which markets consumer products such as Pepsi Cola, Lay's potato chips and Tropicana fruit juice.

She now moves to a role in healthcare at Actavis, which is in the middle of increasing its business with the purchase of Allergan, the makers of Botox and several eyecare products.

Hilado's experience in completing large deals was one of the main appeals for Actavis, according to CEO and president Brent Saunders.

"She will bring extensive expertise in global finance, mergers and acquisitions and business development, and is widely recognised for her exceptional leadership skills,” said Saunders.

Hilado joined PepsiCo in 2009 having spent a year at Schering-Plough as VP and treasurer.

Prior to this role she spent more than 17 years at car manufacturers General Motors, most recently as assistant treasurer.

She also serves on the board of directors of adhesive manufacturer H.B. Fuller and previously served on the board of directors of Bausch & Lomb, a healthcare company that was taken over by Valeant Pharmaceuticals in 2013.

18th November 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics